The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inhibition of histone lysine demethylases with TACH101, a first-in-class pan-inhibitor of KDM4.
 
Chandtip Chandhasin
Employment - Medicenna
Leadership - Medicenna
Stock and Other Ownership Interests - Medicenna
Consulting or Advisory Role - Tachyon Therapeutics
 
Sanghee Yoo
Employment - ImmunoMET
Leadership - ImmunoMET
Stock and Other Ownership Interests - ImmunoMET
Consulting or Advisory Role - Tachyon Therapeutics
Patents, Royalties, Other Intellectual Property - ImmunoMET
 
Joselyn Del Rosario
No Relationships to Disclose
 
Young K Chen
Employment - Bristol-Myers Squibb/Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb/Celgene
 
Jeffrey Stafford
Employment - 858 Therapeutics
Leadership - 858 Therapeutics
Stock and Other Ownership Interests - 858 Therapeutics
Patents, Royalties, Other Intellectual Property - 858 Therapeutics; Jecure Therapeutics
 
Frank Perabo
Employment - ALMS Therapeutics; Barricade Therapeutics; Hinova Pharmaceuticals; InnovatHealth; MAIA Biotechnology; Pattern Pharma; Tachyon Therapeutics
Leadership - Barricade Therapeutics; MAIA Biotechnology; Tachyon Therapeutics
Stock and Other Ownership Interests - Assembly Biosciences; Aurinia Pharmaceuticals; Barricade Therapeutics; Black Diamond Therapeutics; ESSA; MAIA Biotechnology; Tachyon Therapeutics; Turning Point Therapeutics
Consulting or Advisory Role - ALMS Therapeutics; Hinova Pharmaceuticals; Pattern Pharma
 
Michael F. Clarke
Stock and Other Ownership Interests - Tachyon Therapeutics